序号 |
标题 |
次数 |
作者 |
发布时间 |
86986 |
整合素DOTA-E-[cyclo(RGDfK(Acp))]2 |
99 |
zyl |
2024-11-21 |
86987 |
DOTA-E[CYCLO(RGDFK)]2探针多肽 |
125 |
wyh |
2024-11-21 |
86988 |
DOTA-JR-11,1039726-31-2,放射显影多肽 |
119 |
zyl |
2024-11-21 |
86989 |
5-降冰片烯-2-亚甲基环氧丙基醚 , NB-MGE |
109 |
kx |
2024-11-21 |
86990 |
DO3A-Thiol ;CAS:865470-67-3 DOTA-SH |
89 |
wyh |
2024-11-21 |
86991 |
七肽DOTA-VLASSAR,CAS号:1262403-90-6 |
102 |
zyl |
2024-11-21 |
86992 |
Gd-DOTA-HCBP的组成结构 |
118 |
wyh |
2024-11-21 |
86993 |
双阳离子中心咪唑功能化降冰片烯离子液体单体 , NB-O-Im+Br--Im+Br- |
143 |
kx |
2024-11-21 |
86994 |
479081-06-6 ;DOTA-(COOt-Bu)3-NHFmoc-Lys |
112 |
wyh |
2024-11-21 |
86995 |
DOTA-TATE,CAS:177943-89-4, DOTA-3-酪氨酰基-奥曲肽 |
115 |
zyl |
2024-11-21 |
86996 |
DOTA-octreotide的组成与结构 |
103 |
wyh |
2024-11-21 |
86997 |
endo-N-3,5-双三氟甲基联苯基降冰片烯酰亚胺, endo-PTNDI |
114 |
kx |
2024-11-21 |
86998 |
DOTA-Octreotide 大环配体奥曲肽 |
128 |
zyl |
2024-11-21 |
86999 |
端丙炔基聚乙二醇(PTPEG) |
160 |
WYQ |
2024-11-21 |
87000 |
CAS:127985-74-4,DOTA-p-NCS-Bn多肽标记的双功能螯合剂 |
112 |
wyh |
2024-11-21 |
87001 |
降冰片烯-异戊二烯共聚物 ,NBE-IP |
150 |
kx |
2024-11-21 |
87002 |
cyclo(RGDFK(DOTA))的特性与功能 |
104 |
wyh |
2024-11-21 |
87003 |
DOTA-cyclo(RGDfK) |
97 |
zyl |
2024-11-21 |
87004 |
Lu-DOTA-TATE;镥-大环配体-TATE多肽 |
376 |
wyh |
2024-11-21 |
87005 |
顺-5-降冰片烯-内型-2,3-二羧酸二乙酯 , endo-NDDE |
135 |
kx |
2024-11-21 |
87006 |
DOTA-NCS,DOTA-p-NCS-Bn,cas:127985-74-4 |
109 |
zyl |
2024-11-21 |
87007 |
DOTA-PEG-CPP;大环配体DOTA-聚乙二醇-酪蛋白磷酸肽 |
113 |
wyh |
2024-11-21 |
87008 |
Gd-DOTA-COOH 钆-四氮杂环配体-羧基 |
116 |
zyl |
2024-11-21 |
87009 |
DOTA-E「cyclo(RGDfK)2 |
107 |
wyh |
2024-11-21 |
87010 |
DOTA-(Tyr3)-Octreotate;大环配体修饰多肽 |
119 |
wyh |
2024-11-21 |
87011 |
单-6-(4-甲基丙烯酸丙炔基酯-1,2,3-三氮唑)-磺酸基-β-CD(PMA-sulfated-β-CD) |
121 |
WYQ |
2024-11-21 |
87012 |
碘丙炔基正丁氨基甲酸酯(IPBC) |
169 |
WYQ |
2024-11-21 |
87013 |
Gd-DOTA-多肽 |
95 |
zyl |
2024-11-21 |
87014 |
DSPE-PEG-DOTA ;二硬脂酰基磷脂酰乙醇胺- 聚乙二醇-大环化合物 |
305 |
wyh |
2024-11-21 |
87015 |
250612-06-7 ;DOTA-RGDfK dimer |
114 |
wyh |
2024-11-21 |
87016 |
DOTA-GA(tBu)4 cas306776-79-4 大环配体化合物 |
198 |
zyl |
2024-11-21 |
87017 |
250612-06-7 DOTA多肽探针二聚体 |
89 |
wyh |
2024-11-21 |
87018 |
cas:1262403-90-6 七肽DOTA-VLASSAR |
100 |
zyl |
2024-11-21 |
87019 |
DOTA-DGln-DGln-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
95 |
wyh |
2024-11-21 |
87020 |
DOTA-NOC ;619300-53-7 |
107 |
wyh |
2024-11-21 |
87021 |
DOTA-奥曲肽,DOTA-Octreotide |
158 |
zyl |
2024-11-21 |
87022 |
DOTA-PEG5-amine ;DOTA-PEG5-NH2 |
95 |
wyh |
2024-11-21 |
87023 |
DOTA修饰肽,1180007-00-4,二肽Z-GGRDOTA |
97 |
zyl |
2024-11-21 |
87024 |
DOTA-PEG5-amine ;DOTA-PEG5-NH2 |
97 |
wyh |
2024-11-21 |
87025 |
DOTA-RGD,DOTA-cRGDfK |
151 |
zyl |
2024-11-21 |
87026 |
DOTA-Lys-Cys-Acid 二肽DOTA-Lys-Cys |
121 |
wyh |
2024-11-21 |
87027 |
DOTA-Ala-Ala-COOH ;DOTA-丙氨酸-丙氨酸-羧酸 |
133 |
wyh |
2024-11-21 |
87028 |
cas:1293368-74-7,DOTA标记的多肽 |
144 |
zyl |
2024-11-21 |
87029 |
Azido-mono-amide-DOTA ;1227407-76-2 |
84 |
wyh |
2024-11-21 |
87030 |
Gd-DOTA-HCBP-1(多肽核磁共振成像(MRI)探针) |
119 |
zyl |
2024-11-21 |